Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.

Human mutation - 1 Oct 2003

Campos Berta, Díez Orland, Domènech Montserrat, Baena Manel, Balmaña Judith, Sanz Judit, Ramírez Amaya, Alonso Carmen, Baiget Montserrat

Abstract excerpt

Germ-line mutations in the breast cancer susceptibility genes BRCA1 and BRCA2 account for a large proportion of hereditary breast/ovarian cancer families. A large number of disease-causing germ-line mutations and variants of unknown pathological significance have been identified in both genes. The majority of these variants have been studied only in genomic DNA and their effects at the mRNA level have not been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to RNA, Neoplasm

Share to RNA Splice Sites

Share to RNA Splicing

Share to Sequence Analysis, RNA

Source

Identifiers

PMID: 12955719
DOI: 10.1002/humu.9176

Genes

BRCA1
BRCA2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.PMID 12955719Read ↗

Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.Semantic proximity Read ↗

BRCA1 and BRCA2 whole cDNA analysis in unsolved hereditary breast/ovarian cancer patients.Semantic proximity Read ↗

Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes.Semantic proximity Read ↗

Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing.Semantic proximity Read ↗

Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs.Semantic proximity Read ↗

Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression.Semantic proximity Read ↗

Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene.Semantic proximity Read ↗

Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study.Semantic proximity Read ↗

A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.Semantic proximity Read ↗

Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.Semantic proximity Read ↗

A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA.Semantic proximity Read ↗

The variants BRCA1 IVS6-1G>A and BRCA2 IVS15+1G>A lead to aberrant splicing of the transcripts.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.